Skip to content

MGNX

MacroGenics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$4.40
+3.53%
Ask drillr
0
Insider buys (3m)
1
Insider sells (3m)
-$129.1K
Net value (3m)
+10.1%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Aug 20, 2026Peters Jeffrey Stuart · officer: Senior VP, GC, and SecretarySale31,105$4.15
Aug 18, 2026Bonvini Ezio · officer: Sr VP, Research & CSOM-Exempt40,000$2.60
May 20, 2026STUMP DAVID C · directorM-Exempt3,750$0.00
May 20, 2026O'Brien Federica F. · directorA-Award3,750$0.00
May 20, 2026Jackson Scott Thomas · directorM-Exempt3,750$0.00
May 20, 2026Koenig Scott · directorA-Award3,750$0.00
May 20, 2026Liu Margaret · directorA-Award3,750$0.00
May 20, 2026O'Brien Federica F. · directorM-Exempt3,750$0.00
May 20, 2026HEIDEN WILLIAM K · directorM-Exempt3,750$0.00
May 20, 2026HURWITZ EDWARD · directorA-Award3,750$0.00
May 20, 2026HURWITZ EDWARD · directorA-Award22,000$4.52
May 20, 2026O'Brien Federica F. · directorA-Award22,000$4.52
May 20, 2026STUMP DAVID C · directorA-Award22,000$4.52
May 20, 2026Chhabra Meenu · directorA-Award3,750$0.00
May 20, 2026Jackson Scott Thomas · directorA-Award3,750$0.00
May 20, 2026Chhabra Meenu · directorA-Award22,000$4.52
May 20, 2026STUMP DAVID C · directorA-Award3,750$0.00
May 20, 2026Ferrante Karen Jean · directorA-Award3,750$0.00
May 20, 2026Liu Margaret · directorM-Exempt3,750$0.00
May 20, 2026Ferrante Karen Jean · directorM-Exempt3,750$0.00
May 20, 2026Ferrante Karen Jean · directorA-Award22,000$4.52
May 20, 2026Liu Margaret · directorA-Award22,000$4.52
May 20, 2026SIEGEL JAY PHILIP · directorM-Exempt3,750$0.00
May 20, 2026HEIDEN WILLIAM K · directorA-Award3,750$0.00
May 20, 2026Jackson Scott Thomas · directorA-Award22,000$4.52
May 20, 2026Koenig Scott · directorA-Award22,000$4.52
May 20, 2026Chhabra Meenu · directorM-Exempt3,750$0.00
May 20, 2026HURWITZ EDWARD · directorM-Exempt3,750$0.00
May 20, 2026HEIDEN WILLIAM K · directorA-Award22,000$4.52
Feb 17, 2026Karrels James · officer: SVP and CFOA-Award25,000$0.00
Institutional positioning

13F filings over the trailing two quarters

New 32Increased 27Reduced 33Sold out 109
FilerActionSharesFiled
ARMISTICE CAPITAL, LLCReduced6,012,000May 15, 2026
RENAISSANCE TECHNOLOGIES LLCIncreased2,963,559May 14, 2026
MILLENNIUM MANAGEMENT LLCIncreased2,794,357May 15, 2026
VANGUARD CAPITAL MANAGEMENT LLCNew Position2,653,853May 15, 2026
ACADIAN ASSET MANAGEMENT LLCIncreased2,544,000May 13, 2026
TWO SIGMA INVESTMENTS, LPIncreased2,527,829May 15, 2026
BANK OF AMERICA CORP /DE/Increased2,401,814May 18, 2026
MARSHALL WACE, LLPIncreased2,025,526May 15, 2026
RA CAPITAL MANAGEMENT, L.P.New Position1,864,176May 15, 2026
WASATCH ADVISORS LPReduced1,559,701Apr 21, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position1,208,775May 8, 2026
BLACKROCK, INC.Increased1,163,146May 13, 2026
D. E. SHAW & CO., INC.Increased1,058,424May 15, 2026
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.Increased867,249May 11, 2026
CITADEL ADVISORS LLCReduced840,418May 15, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 20, 2026